Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIKASO
NCT06096259Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- May 2024
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in Post-traumatic osteoarthritis (PTOA), sponsored by Brigham and Women's Hospital. Started May 2024; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Post-traumatic osteoarthritis (PTOA)
Beyond the preview
Go deeper on NCT06096259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06096259.